FDA 483 Database
FDA Form 483s Issued in June 2024
Every published Form FDA 483 issued in June 2024, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
12
Published 483s in June 2024
OII FOIA
Source
Form 483s issued in June 2024
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| Brands International Corporation | 3007389902 | OTC Drug Manufacturer | Canada | Jun 21, 2024 | FDA |
| Jubilant HollisterStier General Partnership | 3001623073 | Sterile Drug Manufacturer | Canada | Jun 14, 2024 | FDA |
| AstraZeneca Pharmaceuticals LP Frederick Manufacturing Center | 3002617771 | Active Pharmaceutical Ingredient Manufacturer | USA | Jun 7, 2024 | FDA |
| Mylan Laboratories Ltd. | 3010453141 | Finished Pharmaceutical Manufacturer | India | Jun 26, 2024 | FDA |
| Fagron Compounding Services, LLC | 3012104093 | Outsourcing Facility | Kansas, United States | Jun 28, 2024 | FDA |
| Hikma Injectables USA Inc. | 3022897129 | Outsourcing Facility | New Jersey, United States | Jun 25, 2024 | FDA |
| Carie Boyd Pharmaceuticals | 3010589333 | Outsourcing Facility | Texas, United States | Jun 21, 2024 | FDA |
| Biocon Biosphere Limited | 3022125340 | Finished Pharmaceutical Manufacturer | India | Jun 14, 2024 | FDA |
| Hikma Pharmaceuticals USA Inc. | 2220525 | Outsourcing Facility | New Jersey, United States | Jun 12, 2024 | FDA |
| Torrent Pharmaceuticals Limited | 3005029956 | Active Pharmaceutical Ingredient & Finished Dosage Manufacturer | India | Jun 12, 2024 | FDA |
| Cipla Limited | 3004081307 | Finished Pharmaceutical Manufacturer | India | Jun 21, 2024 | FDA |
| Dr. Reddy's Laboratories Limited CTO -- Unit 6 | 3002949085 | Active Pharmaceutical Ingredient Manufacturer | India | Jun 7, 2024 | FDA |